Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum (IV) warheads
[3] Perovic, D., Kolenc, D., Bilic, V
We proposed to continue to exclude services paid under New Technology APCs
For the laboratory researcher, the two peptides remain interesting tools provided they are used for what they truly are: compounds research use only With a robust but asymmetrical preclinical literature (35 AJSM 2026 studies for BPC-157, muscle/cardiac base for TB-500), and extremely limited human data on both sides, maintaining this nuance helps avoid claims not supported by science and properly position the two peptides within a well-designed research protocol
A US site in North Augusta, South Carolina, is expanding under a stated $121.9 million investment